Blocking cathepsin B protein enhances CAR T-cell therapy effectiveness Drug Target Review 12:55 Tue, 23 Jun
Beyond a waste product: lactate as a master metabolite dictating anti-tumor T-cell fate Nature.com 04:55 Tue, 23 Jun
Novel T-Cell Engager May Be Effective With Daratumumab, Pomalidomide in MM Hematology Advisor 14:56 Mon, 22 Jun
CARsgen Announces Approval of Satri-cel, the World's First car T-Cell Therapy Product for Solid Tumors PR Newswire (Press Release) 12:26 Mon, 22 Jun
Why AbCellera Biologics (ABCL) Is Up 5.5% After New Jazz T-Cell Engager Collaboration Agreement Simply Wall St 12:01 Sat, 20 Jun
Deck Bio to Present Multi-pMHC T Cell Engager Platform at the 8th T-Cell Engager Therapeutics Summit and Bio 2026 PR Newswire (Press Release) 16:31 Thu, 18 Jun
Voro Therapeutics and Alloy Therapeutics Enter Strategic Research Collaboration to Advance Next-Generation Masked T-Cell Engager Therapeutics Business Wire (Press Release) 14:02 Thu, 18 Jun
Jazz and AbCellera sign deal for T-cell engagers in solid tumours Pharmaceutical Business Review 10:49 Thu, 18 Jun
Whole β-glucan particles modulate BCG-induced macrophage and CD4+ T-cell responses via the Dectin-1–JAK1/STAT1 pathway Nature.com 14:09 Wed, 17 Jun
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies Business Wire (Press Release) 12:00 Wed, 17 Jun
Blocking a specific protein improves CAR T-cell therapy success in patients with blood cancers News-Medical.Net 18:35 Mon, 15 Jun
CARsgen Presents Allogeneic car T-cell Products CT0596 and CT1190B at Eha 2026 PR Newswire (Press Release) 01:19 Mon, 15 Jun
Researchers Identify Target with Potential to Improve CAR T-Cell Therapy Response in Patients with Blood Cancers Newswise (Press Release) 22:11 Fri, 12 Jun
‘I can participate in life now’: How CAR T-cell therapy transformed Katie’s life with severe lupus UCLH NHS Foundation Trust (Press Release) 08:53 Fri, 12 Jun
Anti-CD4 monoclonal antibody treatment enhances CD8+ T cell antitumor immunity and suppresses tumor growth in pulmonary fibrosis-associated lung cancer in mice Nature.com 04:27 Fri, 12 Jun
Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant Kras in Pancreatic Cancer Business Wire (Press Release) 08:04 Thu, 11 Jun
New CAR T-Cell Therapy Enables Transplants in Hard-to-Match Kidney Patients Hospimedica 02:35 Wed, 10 Jun
Antengene Presented First Preclinical Data at EULAR 2026 Showing Atg-207 Promotes Regulatory T Cell Induction and Immune Tolerance PR Newswire (Press Release) 01:02 Mon, 08 Jun
Non-gene-edited, CD19-targeted, allogeneic car-T cell therapy for relapsed or refractory B-cell acute lymphoblastic leukemia: an open-label, single-arm phase 1 study Nature.com 02:15 Thu, 04 Jun
CAR T-Cell Therapy Enabled Kidney Transplant in Highly Sensitized Patients Medpage Today 22:07 Wed, 03 Jun
CAR-T cell therapy shows promise for treating rheumatoid arthritis News-Medical.Net 19:11 Wed, 03 Jun
Researchers Aim to Expand Horizons of CAR T-cell Treatment Newswise (Press Release) 17:34 Wed, 03 Jun
T-cell Malignancies Market to Accelerate Substantially at a CAGR of 5.2% During the Forecast Period (2026-2036) | DelveInsight PR Newswire (Press Release) 15:09 Wed, 03 Jun
Cencora to Support U.S. Distribution of Kite’s car T-Cell Therapies Business Wire (Press Release) 13:09 Tue, 02 Jun
Improvement in model flexibility reveals signaling pathway in T cell responses to pulsatile stimuli Nature.com 10:48 Tue, 02 Jun
New T-cell engager therapy shows effectiveness in advanced solid tumors News-Medical.Net 05:46 Mon, 01 Jun
Mage-A4/Mage-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial Nature.com 14:21 Sun, 31 May
Ripk2 promotes CD8+ T cell inactivation and hepatocellular carcinoma progression through Myb/Cxcl9 and Pax5/Adpgk signaling pathways Nature.com 05:56 Fri, 29 May
3D-printed lymph nodes could widen access to car T-cell therapy New Scientist 13:23 Thu, 28 May Article paywall
PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure Newswise (Press Release) 12:21 Thu, 28 May
